Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
129.2 PLN | -1.07% | +0.16% | +50.23% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The group's high margin levels account for strong profits.
- The company is in a robust financial situation considering its net cash and margin position.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+50.23% | 277M | - | ||
+7.15% | 220B | B | ||
+6.60% | 183B | B- | ||
+9.86% | 133B | B- | ||
+24.32% | 107B | A- | ||
-0.95% | 63.05B | A- | ||
+11.04% | 51.74B | B+ | ||
+4.81% | 50.47B | B+ | ||
-1.43% | 40.91B | A | ||
+24.40% | 31.91B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SNT Stock
- Ratings Synektik Spólka Akcyjna